590 related articles for article (PubMed ID: 20133225)
1. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
[TBL] [Abstract][Full Text] [Related]
2. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
3. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy.
Sharma P; Sharma BC; Puri V; Sarin SK
J Hepatol; 2007 Jul; 47(1):67-73. PubMed ID: 17459511
[TBL] [Abstract][Full Text] [Related]
4. Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
Sharma P; Sharma BC; Puri V; Sarin SK
Am J Gastroenterol; 2008 Jun; 103(6):1406-12. PubMed ID: 18510608
[TBL] [Abstract][Full Text] [Related]
5. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
Sharma P; Sharma BC; Puri V; Sarin SK
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of abnormal psychometric tests and critical flicker frequency after clinical recovery of overt hepatic encephalopathy.
Sharma P; Sharma BC; Sarin SK
Neurol India; 2010; 58(2):220-4. PubMed ID: 20508339
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy.
Sharma P; Sharma BC; Tyagi P; Kumar M; Sarin SK
Liver Int; 2009 Feb; 29(2):260-4. PubMed ID: 18710429
[TBL] [Abstract][Full Text] [Related]
8. Predictors of minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC
Saudi J Gastroenterol; 2010; 16(3):181-7. PubMed ID: 20616413
[TBL] [Abstract][Full Text] [Related]
9. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
Sharma P; Sharma BC; Puri V; Sarin SK
Am J Gastroenterol; 2009 Apr; 104(4):885-90. PubMed ID: 19293781
[TBL] [Abstract][Full Text] [Related]
10. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
Sharma P; Sharma BC; Agrawal A; Sarin SK
J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
[TBL] [Abstract][Full Text] [Related]
11. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Agrawal A; Sharma BC; Sharma P; Sarin SK
Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
[TBL] [Abstract][Full Text] [Related]
12. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy.
Romero-Gómez M; Córdoba J; Jover R; del Olmo JA; Ramírez M; Rey R; de Madaria E; Montoliu C; Nuñez D; Flavia M; Compañy L; Rodrigo JM; Felipo V
Hepatology; 2007 Apr; 45(4):879-85. PubMed ID: 17393525
[TBL] [Abstract][Full Text] [Related]
13. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
Sharma BC; Sharma P; Agrawal A; Sarin SK
Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
[TBL] [Abstract][Full Text] [Related]
14. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Urios A; Rodrigo JM; Felipo V
J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
Mittal VV; Sharma BC; Sharma P; Sarin SK
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
[TBL] [Abstract][Full Text] [Related]
16. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.
Kircheis G; Hilger N; Häussinger D
Gastroenterology; 2014 Apr; 146(4):961-9. PubMed ID: 24365582
[TBL] [Abstract][Full Text] [Related]
17. Critical flicker frequency for quantification of low-grade hepatic encephalopathy.
Kircheis G; Wettstein M; Timmermann L; Schnitzler A; Häussinger D
Hepatology; 2002 Feb; 35(2):357-66. PubMed ID: 11826409
[TBL] [Abstract][Full Text] [Related]
18. Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis.
Özel Coşkun BD; Özen M
Turk J Gastroenterol; 2017 May; 28(3):191-196. PubMed ID: 28316320
[TBL] [Abstract][Full Text] [Related]
19. Improving the inhibitory control task to detect minimal hepatic encephalopathy.
Amodio P; Ridola L; Schiff S; Montagnese S; Pasquale C; Nardelli S; Pentassuglio I; Trezza M; Marzano C; Flaiban C; Angeli P; Cona G; Bisiacchi P; Gatta A; Riggio O
Gastroenterology; 2010 Aug; 139(2):510-8, 518.e1-2. PubMed ID: 20470775
[TBL] [Abstract][Full Text] [Related]
20. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
